{"id":"W2540798315","doi":"10.1016/j.jval.2016.09.1882","title":"Cost Effectiveness of Empagliflozin in Patients with T2DM and High CV Risk in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); Boehringer Ingelheim (Canada)","funders":"","keywords":"Empagliflozin; Medicine; Cost–benefit analysis; Quality-adjusted life year; Hazard ratio; Demography; Emergency medicine; Cost effectiveness; Confidence interval; Internal medicine; Type 2 diabetes; Diabetes mellitus; Risk analysis (engineering); Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006510268,0.0002357282,0.0007733724,0.0007295433,0.001057345,0.001596183,0.0008753881,0.000659542,0.002592021],"category_scores_gemma":[0.006063413,0.0002676109,0.001537237,0.002549018,0.0004974173,0.000504008,0.0006783217,0.001269159,0.00008580332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0466881,"about_ca_system_score_gemma":0.04021289,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9814721,"about_ca_topic_score_gemma":0.9862206,"domain_scores_codex":[0.9990804,0.0001761067,0.00007490334,0.00008327098,0.0002681798,0.0003170444],"domain_scores_gemma":[0.9970433,0.0006013892,0.0004548698,0.00004538625,0.0007396853,0.001115341],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007500614,0.0007853352,0.8969218,0.0007153075,0.00187572,0.0005413567,0.0003267542,0.006387135,0.0001839114,0.001690141,0.01264362,0.0704283],"study_design_scores_gemma":[0.00135492,0.0004719236,0.9828089,0.0004097904,0.001375874,0.0002831708,0.0009848996,0.008491107,0.0001043024,0.0004808872,0.003170404,0.00006389576],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9727835,0.009836727,0.00010962,0.006025854,0.0001025111,0.00007863907,0.004405953,0.00001630486,0.00664086],"genre_scores_gemma":[0.9955845,0.002278351,0.0001474255,0.0004156485,0.00003479525,0.00001255462,0.0009389958,0.000004384019,0.0005833271],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0466881,"threshold_uncertainty_score":0.3387475,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01397248930504762,"score_gpt":0.2453143714053366,"score_spread":0.231341882100289,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}